Death in the Balance

In 1997, to the surprise of many researchers, mitochondria reclaimed the limelight of apoptosis research when several groups observed that cytochrome c released from the mitochondria could induce apoptosis in cell-free systems.1,2 A hot research topic decades ago, mitochondria excitement cooled in the 1970s when researchers agreed on the mechanisms of oxidative phosphorylation (ox-phos). Now, mitochondria-mediated apoptosis is believed to be central to a number of major debilitating diseases, in

Written byLaura Defrancesco
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

Just why mitochondria assume this seemingly disparate role is the subject of speculation. Neil Blackstone, associate professor of biological sciences, Northern Illinois University, DeKalb, and Douglas Green, head of the division of immunology at the La Jolla Institute for Allergy and Immunology, Ontario, Calif., believe that it is an evolutionary issue, one that goes back to the mitochondria's roots as an endosymbiont.5 They suggest that after ancient eukaryotes took in protomitochondria, mitochondria were forced to interact with their environment through their hosts. The protomitochondria weren't completely at the eukaryotes' mercy, however; they could manipulate the host cell phenotype with by-products of ox-phos, and, in particular, reactive oxygen species (ROSs).

ROSs raise the mutation rate and, some think, sexual recombination along with it.6 In good times, that is, times of rapid growth, the mitochondria would crank out adenosine triphosphate (ATP), keeping the redox state of the mitochondria fully oxidized. However, during ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies